The development of T cell tolerance in the thymus requires the presentation of host proteins by multiple antigen-presenting cell (APC) types. However, the importance of transferring host antigens from transcription factor AIRE-dependent medullary thymic epithelial cells (mTECs) to bone marrow (BM) APCs is unknown. We report that antigen was primarily transferred from mTECs to CD8a + dendritic cells (DCs) and showed that CD36, a scavenger receptor selectively expressed on CD8a + DCs, mediated the transfer of cell-surface, but not cytoplasmic, antigens. The absence of CD8a + DCs or CD36 altered thymic T cell selection, as evidenced by TCR repertoire analysis and the loss of allo-tolerance in murine allogeneic BM transplantation (allo-BMT) studies. Decreases in these DCs and CD36 expression in peripheral blood of human allo-BMT patients correlated with graft-versus-host disease. Our findings suggest that CD36 facilitates transfer of mTEC-derived cellsurface antigen on CD8a + DCs to promote tolerance to host antigens during homeostasis and allo-BMT.
In Brief
How cooperative antigen presentation between medullary thymic epithelial cells (mTECs) and dendritic cells (DCs) occurs remains unknown. Perry et al. show that CD36, a scavenger receptor expressed on CD8a + DCs, mediates acquisition and presentation of cell-surface antigens from mTECs for T cell receptor repertoire development and allo-tolerance during bone marrow transplantation.
INTRODUCTION
During T cell development, T cell receptor (TCR) gene segments are rearranged to generate a diverse TCR repertoire necessary for immunity to invading pathogens (Klein et al., 2014; Vrisekoop et al., 2014; Weissler and Caton, 2014 ). An unintended consequence of this diversity is the recognition of self-antigen, which can result in autoimmunity. For T cells, two fundamental processes promote tolerance to self in the thymus (referred to as central tolerance) prior to their release into the periphery:
(1) negative selection, whereby autoreactive T cells are eliminated; and (2) generation of CD4 + forkhead box P3 (Foxp3) + regulatory T (Treg) cells (Bluestone et al., 2015; Klein et al., 2014; Li and Zheng, 2015; Richards et al., 2016) . Both processes are driven by TCR recognition of self-antigens presented by antigen-presenting cells (APCs). Although this can occur throughout the thymus, it commonly occurs in the thymic medulla and involves both medullary thymic epithelial cells (mTECs) and bone marrow (BM)-derived dendritic cells (DCs), B cells, and macrophages (Chan and Anderson, 2015; Klein et al., 2014; Oh and Shin, 2015; Perry and Hsieh, 2016) . mTECs can directly present peripheral tissue antigens (PTAs) generated via the transcription factor AIRE via non-conventional mechanisms to tolerize CD4 + T cells (Aschenbrenner et al., 2007; Cowan et al., 2013; Hinterberger et al., 2010; Perry et al., 2014) . It has become increasingly clear, however, that thymic tolerance to PTAs can occur via antigen transfer from mTECs to BM-derived APCs (Gallegos and Bevan, 2004; Hubert et al., 2011; Koble and Kyewski, 2009; Lin et al., 2016; Millet et al., 2008; Perry et al., 2014) . Recently, we proposed that CD8a + DCs are the primary BM APC recipient of antigen transfer from mTECs (Perry et al., 2014) . Our conclusion was based on an assessment of eight TCRs for their ability to induce Treg cell development in basic leucine zipper transcriptional factor ATF-like 3 (Batf3) -/-mice, which are deficient in CD8a + DCs. These data are consistent with a recent study using a different TCR that recognizes an AIRE-dependent mTEC antigen and yet involves antigen presentation by non-migratory BM APCs which include CD8a + DCs (Lin et al., 2016) (Ardouin et al., 2016) . However, a recent report argued that BATF3-dependent CD8a + DCs are not involved in thymic Treg cell selection based on analysis of two Treg cell TCRs and of TCR repertoires using a different fixed-TCRb chain (Leventhal et al., 2016) . Thus, the importance of BATF3-dependent CD8a + DCs in thymic selection, their role in antigen transfer from mTECs, and the mechanisms by which this occurs, remain unclear.
Here, we quantified the importance of CD8a + DCs in shaping the conventional T cell (Tconv) and Treg TCR repertoire and their involvement in facilitating Treg cell generation to AIRE-dependent self-antigens. We also showed that CD36, a class B scavenger receptor preferentially expressed on CD8a + DCs, is important for the transfer of a model cell-surface, but not cytoplasmic, antigen from mTECs. This mechanism of antigen transfer was critical for the development of thymic allo-tolerance during bone marrow transplantation (BMT) in mice and may be important for the prevention of graft-versus-host disease (GVHD) after human allo-BMT. Thus, these data suggest a model by which CD8a + DCs utilize CD36 to cross-present cell-surface antigens from mTECs to mediate thymic T cell tolerance.
RESULTS

BATF3-Dependent BM APCs Facilitate Thymic Treg Cell TCR Repertoire Development
The role of BATF3-dependent CD8a + DCs on thymic tolerance is controversial, with studies suggesting that they are either irrelevant (Leventhal et al., 2016) or important (Perry et al., 2014) for thymic Treg cell selection. To address this, we assessed the impact of Batf3 deficiency globally on the TCR repertoire. Because of the great diversity of the normal TCR repertoire, we utilized a fixed TCRb model as previously described (Perry et al., 2014) Chai et al., 2017) , whose frequencies were not affected by Batf3 deficiency ( Figures 1A and 1B) . We found differences within the Tconv and Treg TCR repertoires using unbiased factor analysis that showed minimal inter-mouse variability while primarily clustering around Batf3-deficient and -sufficient groups ( Figure 1C ). This was partly due to a number of TCRs enriched in Batf3-deficient mice, suggestive of CD8a + DC-mediated negative selection ( Figure 1C , top plots, data points found below reference line), as shown in our previous study (Perry et al., 2014) . In total, BATF3-dependent DCs negatively selected $2% of the unique Tconv and Treg cell TCR repertoires ( Figures 1D and S1B) .
By contrast to BATF3-dependent negative selection, we observed a greater requirement for CD8a + DCs in Treg cell selection ( Figure 1C , top plot, red dots above reference line). TCRs that we previously identified as BATF3 dependent in vivo (Perry et al., 2014) were also decreased in our Batf3-deficient Treg TCR dataset ( Figure S1C ). We observed that CD8a + DCs were required for selection of approximately 12% of the unique Treg cell TCR repertoire ( Figures 1E and S1D) . However, these conclusions were different from a previous report showing no role for CD8a + DCs in thymic Treg cell generation using Batf3 -/-mice (Leventhal et al., 2016) . Analysis of their dataset (Leventhal et al., 2016) using our approaches revealed that 5%-10% of their Treg TCR repertoire is BATF3 dependent (Figure S1E) , suggesting that the differences in interpretation may be due to the statistical methods used. Thus, we propose that both TCR repertoire studies support a role for BATF3-dependent CD8a + DCs in thymic Treg cell selection.
AIRE-Dependent Antigens Are Transferred to and
Presented by CD8a + DCs AIRE plays an important role in T cell tolerance, in part via the induction of PTAs in mTECs. AIRE-dependent antigens can be presented autologously on mTECs, and may also be transferred to CD8a + DCs (Ardouin et al., 2016; Hubert et al., 2011; Koble and Kyewski, 2009; Perry et al., 2014) . Although we had previously assessed the AIRE-dependent repertoire using analysis of TRAV14 TCRs, we generated new data using multiplex PCR to permit direct comparison with the BATF3 dataset. Within the range of previous results, we found that AIRE was involved in the deletion of both Tconv ($4%) and Treg ($3%) cells as well as Treg cell selection ($10%) ( Figures S2A-S2D) .
We then assessed the overlap of TCRs that are dependent on CD8a + DCs versus those dependent on AIRE-induced self-antigens in mTECs. While we observed relatively few Tconv TCRs that were co-dependent on BATF3 and AIRE for negative selection, a much greater fraction of Treg TCRs were co-dependent, consistent with AIRE-dependent antigen transfer from mTECs to CD8a + DCs ( Figures 1F, 1G , S2E, and S2F). In fact, $40% of AIRE-dependent Treg TCRs were co-dependent on CD8a + DCs ( Figure 1G ). In summary, the cross-comparison of BATF3-and AIRE-dependent TCRs supported our previous proposal that a substantial fraction of Aire-dependent antigens is transferred to and presented by CD8a + DCs. 
Tcrd
-/-mice and assessed tissue inflammation using both positron emission tomography (PET) and histology ( Figures  2A-2C ). We observed a number of tissues, particularly the lungs, with increased inflammation in mice receiving cells from either Aire-or Batf3-deficient mice (Figures 2A-2C and S3A ). In addition to polyclonal T cells, we asked whether pathology could be induced by Tconv cells expressing the BATF3-and AIREcodependent Treg TCR G25 (Perry et al., 2014) . Transgenic mice were generated bearing the thymic Treg TCR G25 and a reporter of Foxp3 (Foxp3 IRES-GFP ). Cells from naive G25 transgenic Foxp3 IRES-GFP Rag1 -/-mice induced weight loss ( Figure 2E ) and lung inflammation in Tcrb
-/-mice reminiscent of polyclonal T cell transfers from Batf3-or Aire-deficient mice. Thus, these data supported the notion that BATF3, like AIRE, contributes to the induction of thymic T cell tolerance. Batf3-deficient mice are not reported to develop spontaneous autoimmunity (Hildner et al., 2008) . We hypothesized that although harboring defective central tolerance, the delayed or absence of autoimmunity observed in these mice may be due to a defect in antigen presentation in the periphery. Consistent with this hypothesis, Batf3 deficiency abrogates the development of type 1 diabetes in the non-obese diabetes (NOD) model (Ferris et al., 2014) . To further test this possibility, we asked whether peripheral CD8a + DCs were required to activate cells expressing thymic BATF3-dependent Treg TCRs in vivo. We assessed the proliferation of naive G25 TCR transgenic cells ( Figure 2F ), and CD44 upregulation in seven other TCRs (Perry et al., 2014) retrovirally transduced into the human CLIP antigen-specific TCliab TCR transgenic Rag1 -/-CD4 + cells ( Figure S3B ; Hsieh et al., 2006) . This analysis of eight TCRs supported the hypothesis that BATF3-dependent CD8a + DCs are involved in presenting a distinct array of antigens in both the thymus as well as the periphery. candidate, CD36, expressed at a much higher level on thymic and splenic CD8a + DCs compared with other DC subsets. CD36 is reported to recognize phosphatidylserine (PS) (Rigotti et al., 1995) and may facilitate the acquisition and cross-presentation of antigens derived from apoptotic cells in some studies (Albert et al., 1998) though not others (Belz et al., 2002; Schulz et al., 2002) . CD36 on CD8a + DCs may thereby facilitate antigen transfer, as apoptosis is part of the normal mTEC life cycle (Gray et al., 2007) . We first confirmed that CD36 was uniquely expressed on the CD8a + subset of thymic DCs ( Figure 3A ). Similar to Batf3 deficiency ( Figures 1A and 1B) , we did not observe effects of CD36 deficiency on overall CD4SP, Tconv, or Treg cell frequencies (Figures S4A and S4B) . We then tested whether CD36 was involved in the transfer of cell-surface antigens using BM chimeras into BALB/c hosts that express the MHCII molecule Ea. As C57BL/6 mice do not express Ea, the preferential generation of Ea:I-A b complexes on CD8a + versus SIRPa + DCs (Ardouin et al., 2016; Perry et al., 2014) , as detected using the peptide-in-groove antibody Y-Ae, occurs via antigen transfer from mTECs ( Figure 3B ; Humblet et al., 1994) . This was markedly diminished in CD8a + DCs from Cd36 -/-BM ( Figure 3B ). CD36 expression was concomitant with Ea presentation as well as high MHCII and CD80 levels ( Figure S4C ). However, the decreased Ea presentation observed in Cd36 -/-BM chimeras was not a result of lower MHCII levels ( Figure 3C ). Thus, CD36 is required for the transfer of cell-surface antigens from mTECs to CD8a + DCs.
CD36 Is Involved in
We also asked whether CD36 was involved in mediating antigen transfer of cytoplasmic GFP antigen from mTECs using the Adig BAC transgene, in which GFP is expressed via the Aire promoter (Gardner et al., 2008) . Analysis of Cd36 +/+ BM donor APC subsets into Adig + hosts confirmed our previous conclusion that CD8a + DCs preferentially acquired GFP from host mTECs ( Figure 3D ) but did not do so in a CD36-dependent manner. Additionally, we tested a second intracellular source of antigen using the mitochondrial-localized GFP reporter mouse (mito-GFP). Similar to cytosolic-localized GFP, TEC-derived, mito-GFP was transferred to CD8a + DCs in a CD36-independent manner ( Figure S4D ). Thus, these studies of model antigens demonstrated that CD36 is important for cell-surface, but not cytoplasmic-or mitochondrial-derived, antigen transfer from mTECs to CD8a + DCs 
CD36 Facilitates Tconv and Treg Cell TCR Repertoire Development
Though the effect of Cd36 deficiency on the transfer of mTEC Ea was substantial, it remained possible that this was a unique interaction between CD36 and Ea. We therefore tested whether Cd36 deficiency affected the thymic TCR repertoire as above. We found no major shifts in the TCR repertoire ( Figure 4A , top panels, points on the diagonal). An overall normal T cell selection process is consistent with the observation that thymocytes rarely express CD36 (ImmGen, Figure S4E ). However, the TCR repertoire analysis revealed a requirement for CD36 for negative selection of a subset of the Tconv ($3%) and Treg ($5%) cell TCR repertoire and the selection of $7% of the Treg cell TCR repertoire ( Figures 4A-4C and S4F ). In addition, we corroborated our sequencing data with in vivo Treg cell development studies using retroviral transduction of Cd36 +/+ Rag1 -/-thymocytes with CD36-dependent (R35, R117) and -independent (G25, G41) Treg cell TCRs ( Figures 4D and 4E ), which we previously found were BATF3 and AIRE codependent (Perry et al., 2014) . Four Treg TCRs that are not dependent on BATF3 or AIRE were also not affected by CD36 absence in vivo as expected ( Figure S4G ). Taken together, these data demonstrated that CD36 exerts T cell-extrinsic effects on the Treg and Tconv cell TCR repertoire.
By cross-referencing our datasets from Cd36-and Batf3-deficient conditions, we observed that many BATF3-dependent TCRs were not affected by CD36, suggesting that CD36 does not globally affect CD8a + DC antigen presentation ( Figure 4F ).
However, the majority of our CD36-dependent TCRs were BATF3 dependent ( Figure 4F ), suggesting that the effect of CD36 on the TCR repertoire is primarily due to its expression on CD8a + DCs and not macrophages. We then asked whether CD36 was important for antigen transfer, which we infer based on TCRs that are codependent on AIRE and BATF3. Of the few Tconv cell TCRs codependent on BATF3 and AIRE for negative selection, 50% were also dependent on CD36 ( Figure 4F, left diagram) . Similarly, approximately 60% of the Treg cell TCRs codependent on BATF3 and AIRE also required CD36 for Treg cell selection ( Figure 4F , right diagram). Though it remains unknown how prevalent antigen presentation via transfer of cell-surface or cytoplasmic antigens is in vivo, inspection of AIRE-dependent tissue-restricted transcripts revealed that $25% have a trans-membrane domain by GO (207/804 genes; >50 counts, 103 enriched versus Aire -/- [Sansom et al., 2014] ). This is similar to the percentage of TCRs that we observe to be BATF3, CD36, and AIRE dependent (27/105 AIRE-dependent TCR). Thus, these data suggested that CD36 contributes substantially to cooperative antigen presentation of AIRE-dependent antigens by BATF3-dependent CD8a + DCs for the development of the Treg and Tconv cell TCR repertoires.
CD36 Acquires Cell-Surface Antigen via Scavenging of Apoptotic Bodies
We next sought to determine the process by which CD36 facilitated antigen acquisition from mTECs in vitro. As we are not aware of an Aire + H-2 d -expressing mTEC line, we used the TA3 hybridoma line as an imperfect surrogate (Glimcher et al., 1983) . To assess antigen transfer, cell trace violet (CTV)-labeled BM-derived CD24 + DCs (BMDCs), which are of a similar developmental lineage as thymic CD8a + DCs (Naik et al., 2005) , were co-cultured with apoptotic GFP + TA3 cells for 6 hr (Figure S5A ). Transfer and presentation of TA3-derived Ea on I-A b in DCs was CD36 dependent (Figure 5A ), consistent with our in vivo data ( Figure 3B ). To demonstrate that our findings were not confounded by the use of BM-derived DCs, we isolated thymic DCs from Cd36-deficient and -sufficient mice, followed by co-culture with apoptotic TA3 cells. As observed with CD24 + BMDCs, the absence of CD36 resulted in significantly decreased presentation of Ea ( Figure S5B ). To rule out that our observations are due to an underlying developmental phenotype, we isolated and cultured Cd36-sufficient thymic CD11c + DCs with apoptotic TA3 cells in the presence or absence of a CD36 blocking antibody. Similar to our findings with both CD24 + BMDCs and CD8a + thymic DCs, we observed significant reduction in Ea presentation by thymic CD8a + DCs ( Figure S5C ).
GFP was not detected with DCs by flow cytometry ( Figure S5A ), which suggested that the apoptotic bodies were not stuck to DCs in this in vitro system, although GFP transfer appeared to occur in vivo ( Figure 3D ). CD36-mediated acquisition of I-Ea could be via endocytosis, and/or directly to the DC cell membrane via trogocytosis or related processes followed by MHC internalization. Consistent with the latter, we observed diminished I-A d expression on
Cd36-deficient CD24 + DCs after co-culture with apoptotic GFP + TA3 cells ( Figure 5B ). We also asked whether I-A d could be picked up in this manner by CD8a + DCs in vivo. However, it appeared that the process of enzymatic digestion at 37 C for DC isolation resulted in cell-surface MHC transfer ( Figure S5D ), rendering the in vivo analysis uninterpretable. By contrast, the 30 min digestion with APCs of different MHC haplotypes did not generate Ea:I-A b complexes detectable by Y-Ae (Figure S5D) , implying that generation of Y-Ae on CD8a + DCs in our BM chimeras ( Figure 3B ) must have occurred in vivo. In summary, our in vitro data suggested that CD36 may be involved in the transfer of intact cell surface MHC molecules to be displayed on CD8a + DCs.
CD36 has several known ligands, including PS and thrombospondin on apoptotic bodies or exosomes that could be involved in antigen transfer from mTECs. To assess the role of apoptotic bodies, we pre-treated GFP + TA3 cells with the pan-caspase inhibitor z-VAD-FMK prior to co-culture with CTV + CD24 + DCs. Inhibition of apoptosis resulted in significantly diminished acquisition and presentation of Ea, which was further decreased in conjunction with Cd36 deficiency ( Figure 5C ). To assess the role of exosomes, we co-cultured GFP + TA3 cells and CTV + CD24 + DCs separated by a 0.4 mm membrane sufficient to allow access to exosomes but restrict passage of larger bodies (e.g., apoptotic bodies). This reduced the acquisition and presentation of Ea, arguing against a role for exosomes (Figure 5C ). However, it remains possible that TA3 generates fewer exosomes than mTECs or that the concentration of exosomes generated was insufficient to overcome the different physical characteristics of the culture system. While these data cannot (legend continued on next page) exclude a role for exosomes in vivo, these in vitro data supported the published notion that CD36 is involved in the recognition of apoptotic bodies. We next sought to test whether apoptosis was required for Ea acquisition and presentation in vivo. To do so, we performed C57BL/6/BALB/c BM chimeras but treated mice with either the pan-caspase inhibitor z-VAD-FMK or vehicle for 3 days prior to harvest. We found that CD8a + DCs from mice treated with z-VAD-FMK presented significantly less Ea than vehicle-treated mice ( Figure S5E ). Along with ''eat me'' signals, the phagocytosis of apoptotic cells also requires a signal to home to a dying cell (''find me''), including purine nucleosides and nucleotides, such as ATP (Poon et al., 2014 Figure 5D ). Additionally, we treated C57BL/6/BALB/c BM chimeric mice with either the purinergic receptor inhibitor Suramin or vehicle for 3 days prior to harvest. We found that CD8a + DCs from mice treated with Suramin presented significantly less Ea than vehicle-treated mice ( Figure S5F ). Taken together, our in vitro and in vivo data supported the notion that CD8a + DCs use CD36 to acquire cell-surface antigens from apoptotic mTECs.
CD36-Dependent Antigen Transfer Is Necessary for Direct Allo-tolerance Development
Based on previous reports (Dolan et al., 2006; Li et al., 2012; Mazzini et al., 2014; Qu et al., 2009) , as well as our in vitro observation that MHCII can be transferred directly to the cell surface of CD8a + DCs, we asked whether this might be involved in the development of thymic tolerance in vivo during allo-mismatched BMT. To test this, we generated fully MHC mismatched allogeneic BM chimeras using C57BL/6 (B6) donors and BALB/c hosts.
To assess whether thymic allo-tolerance was achieved, mature CD25 -Tconv thymocytes from these mice were used to induce acute graft-versus-host disease (GVHD) in the context of a new BM transplant ( Figure 6A ). As expected, mice receiving thymic Tconv cells from Batf3 +/-B6/BALB/c BM chimeras showed minimal evidence of acute GVHD compared with those receiving Tconv cells from B6/B6 autologous BM chimeras that have never been exposed to H-2 d ( Figure 6B ). The process of BM chimera generation did not appear to affect the ability of thymocytes to induce acute GVHD, as Tconv cells from syngeneic B6 BM chimeras were equivalent to those from normal B6 mice (Figure S6A) . Thus, these data confirmed that thymic T cell tolerance to host MHC occurs during allogeneic BM transplantation.
By contrast, loss of thymic tolerance to host antigens occurred with deficiency in either BATF3 or CD36 in the donor B6 background BM. Thymic Tconv cells from the respective BM chimeras induced acute GVHD as assessed by weight loss, clinical score, and time to euthanasia ( Figure 6B ). Tconv cells from Cd36 -/-/BALB/c chimeras were marginally less potent than Batf3 -/-/BALB/c chimeras, consistent with the incomplete block of MHC transfer with Cd36 deficiency ( Figure 3B ). We did not find evidence for a cell-intrinsic T cell hyper-reactivity imparted by Batf3 deficiency, as T cells from non-chimeric Batf3-deficient and -sufficient mice showed similar induction of GVHD ( Figure S6B ). Moreover, Cd36-deficient and -sufficient thymocytes isolated from mixed BM chimeras with B6 hosts showed no difference in their ability to induce GVHD (Figure S6C) , suggesting that expression of CD36 on T cells is not critical for this immune response. Thus, these data suggested that CD36-dependent MHC transfer to CD8a + DCs is required for thymic allo-tolerance. Allo-recognition can occur via direct recognition of allogeneic MHC by the TCR or indirectly via recognition of allogeneic peptides presented on self-MHC (e.g., Ea peptide on I-A b ). To test direct allo-recognition, we cultured sorted thymic Tconv cells in the presence of irradiated BALB/c splenocytes ( Figure 6A ). Tconv cells from Batf3 +/-/BALB/c chimeras showed minimal proliferation, consistent with the in vivo results suggesting that these cells were allo-tolerant ( Figure 6C ) from Batf3-or Cd36-deficient donors was lower than Tconv cells from non-tolerant conditions using autologous B6 hosts ( Figure 6C ), suggesting that partial allo-tolerance did occur to host MHC presented on cTECs and mTECs. A deficiency in tolerance to direct allo-recognition was also consistent with the early time course of GVHD in vivo ( Figure 6B ), as donor APCs would not have seeded the periphery in large numbers. Additionally, it was unlikely that the observed phenotype is due to killing of BM by donor T cells because mice lethally irradiated that received no BM did not exhibit any of the clinical features observed in our GVHD model (data not shown).
Our finding that both CD8a + DCs and CD36 were required for allo-tolerance development in mice predicted that patients who receive partial HLA-mismatch BMT may depend on donor BMderived CD141 + DCs (the human equivalent of CD8a + DCs) and CD36 to develop thymic allo-tolerance and prevent chronic GVHD (cGHVD). To address this, we performed a blinded analysis of peripheral blood mononuclear cell samples collected 30 days after transplantation from a cohort of allo-BMT recipients, some of whom developed cGVHD ( Figure S7A ). We observed that patients who develop cGVHD had significantly fewer CD141 + DCs, which expressed lower levels of CD36 (Figures 7A and S7B), regardless of demographic or clinical characteristics (c 2 = 18.7, df(2), p < .001). We observed no significant differences in white blood cell count, neutrophil count, or neutrophil frequency ( Figure 7A ), nor in blood monocyte populations, plasmacytoid DCs, or CD1a + DCs ( Figure S7C) . Thus, the development of cGVHD was associated with decreased abundance of CD141 + DCs and CD36 expression. In summary, these data supported a model in which the efficiency of CD8a + (CD141 + ) DC reconstitution after allogeneic BMT was associated with the induction of tolerance to direct host MHC recognition via CD36-dependent transfer of thymic CD8a + DCs ( Figure 7B ).
DISCUSSION
Although the process of self-antigen transfer from mTECs to BM APCs has been recognized for more than two decades, its impact on thymic T cell development and the mechanism(s) by which this process occurs has not been described. We made the following observations. First, antigen transfer to CD8a + DCs made a significant contribution to AIRE-dependent thymic tolerance based on TCR repertoire analysis in a fixed TCRb model. Second, antigen transfer from AIRE-expressing mTECs to CD8a + DCs occurred via at least two distinct routes that segregate between cell-surface and cytoplasmic antigens. Third, cell-surface antigen transfer was dependent on CD36, a scavenger receptor preferentially expressed on the CD8a + subset of DCs. Fourth, CD36-mediated antigen transfer resulted in the initial display of mTEC cell-surface proteins on DCs. Finally, this process is required for allo-tolerance in murine BMT, and, in initial studies, may also be relevant for humans. Thus, our data demonstrated that antigen transfer can occur via multiple pathways and suggested that CD36-mediated uptake of cell-surface proteins by CD8a + DCs plays an important role in tolerance to mTEC-derived antigens.
Previous studies suggest that thymic CD8a + DCs are important in thymic tolerance (Lei et al., 2011; Lin et al., 2016; Perry et al., 2014) . Here, we have quantified the effect of Batf3 deficiency on the CD4SP TCR repertoire in a fixed TCRb model. The analysis of a fully polyclonal repertoire introduces the experimental complexity of pairing a and b chains for sequencing, as well as increased mouse-to-mouse variability due to the much greater repertoire diversity. With this restriction of the repertoire in mind, our results demonstrated that BATF3-dependent DCs affect both negative selection and Treg cell selection. Crosscorrelation with the effect of AIRE on the TCR repertoire led to an estimate that CD8a + DCs contributes to only $6% of AIREdependent negative selection of Tconv cells, versus $20% and $40% for AIRE-dependent deletion and Treg cell selection, respectively. Thus, our data showed that CD8a + DCs affect thymic T cell selection and play an important role via cooperative antigen presentation with mTECs. The mechanism utilized by CD8a + DCs to acquire cell-surface
antigens from mTECs appears to be the recognition of apoptotic bodies by CD36. CD36 is expressed on thymic CD8a + DCs but not SIRPa + or pDCs and is reported to bind PS present on apoptotic bodies. We found using TCR repertoire analysis that CD36 was involved in both negative selection and Treg cell differentiation with a strong bias toward co-dependence with BATF3 and AIRE, implying that CD36 plays a role in antigen transfer to CD8a + DCs. In addition, absence of CD36 resulted in the loss of CD8a + DC acquisition and presentation of membrane-bound I-Ea antigen from mTECs in vivo. Finally, deficiency in the purinergic receptor P2Y14, which recognizes UDP potentially released by apoptotic cells, decreased CD8a + DC presentation of cell-surface-bound antigen acquired from mTECs. Taken together, these data suggested a model in which mTECs mature, express AIRE, and ultimately undergo apoptosis to generate bodies that are recognized by CD36 on CD8a + DCs.
The observation that MHC is directly transferred to the CD8a + DC cell surface brings up the possibility that mTEC-loaded peptide:MHC complexes directly mediate negative selection or Treg cell differentiation (Koble and Kyewski, 2009 ). Alternatively, mTEC-derived cell surface antigens can be internalized, degraded, and loaded onto MHCII as detected by the peptidein-groove antibody Y-Ae. This mechanism could explain the observation of antigen transfer using the RIP-mOVA transgene (Koble and Kyewski, 2009 ), which expresses a transmembrane protein that encodes the OVA peptide. Understanding which cell-surface proteins are transferred from mTECs has unfortunately been limited by the possibility of cross-contamination during our thymic DC preparation protocol. Future studies are required to determine the relative importance of CD8a + presentation of intact peptide/MHC transferred from mTECs versus internalization and presentation of mTEC-associated cell-surface antigens.
Our finding in mice that CD8a + DCs, partially through CD36, mediated allo-tolerance development, led us to question whether this phenomenon may also be relevant to human In summary, these data suggested that antigen transfer from mTECs is mediated to a large part by CD8a + DCs via CD36
and is demonstrably important to thymic T cell selection and the shaping of the TCR repertoire. We have also determined that CD36 is required for direct transfer of MHC and presumably other cell-surface proteins from mTECs onto the cell surface of CD8a + DCs. One intriguing hypothesis is that defects in this pathway may lead to loss of tolerance to cell-surface proteins, potentially contributing to antibody-mediated diseases such as Graves autoimmune thyroiditis that target cell-surface receptors. In a similar vein, defects in the transfer of cell-surface antigens may contribute to the loss of allo-tolerance during BMT, resulting in chronic graft-versus-host disease.
STAR+METHODS
Detailed methods are provided in the online version of this paper and include the following: 
STAR+METHODS KEY RESOURCES TABLE
(data not shown). G25 TCR transgenic mice were bred to Foxp3 IRES-GFP Rag1 -/-mice. Animals were typically 6-10 weeks old at the time experiments were performed and consisted of males and females.
Human Samples
Peripheral blood samples were banked pre and post hematopoietic stem cell transplantation on an IRB approved institutional tissue repository protocol after recipients provided informed consent. Blood samples were collected in EDTA blood tubes at days 30 after transplant. Peripheral blood mononuclear cells were isolated by Ficoll gradient and control rate frozen and stored under liquid nitrogen until use. White blood cell count, absolute neutrophil count, and neutrophil frequency were obtained via clinical complete blood count analysis from the same blood draw. Samples were de-identified and assigned a unique patient number, then clinically annotated for chronic GVHD retrospectively using clinical records. Patient population characteristics, including age, gender, reason for bone marrow transplantation, donor type, HLA match grade, GVHD symptoms, time of GVHD onset, and days since last follow-up can be found in Figure S7 .
METHOD DETAILS
Reagents, antibodies and flow cytometry Fluorescently conjugated monoclonal antibodies were purchased from Biolegend, eBioscience, and Becton Dickenson. Y-Ae anti-I-A b :Ea (52-68) peptide was obtained from eBioscience. Samples were analyzed using a FACSAria or FACSCanto (Becton Dickinson) and data were processed with FlowJo X (Treestar).
Thymic dendritic cell isolation and staining
Thymus was mechanically separated with scissors and digested with Liberase TL (125 mg/ml, Roche) and DNase I (50 mg/ml, New England Biolabs) in DMEM for 30 min at 37 C. Cells were stained with 2.4G2, B220, MHCII, CD11c, CD11b, CD8a, SIRPa, CD24 and experiment-specific antibodies as indicated. DC subsets were identified as follows: Assessment of thymic Treg cell selection in vivo As described previously (Bautista et al., 2009) , TCRa chains of interest were cloned into the MigR1-TCRa-P2A-TClib retroviral vector. Foxp3 IRES-GFP Rag1 -/-thymocytes were transduced with TCRs in vitro, injected intrathymically into sublethally (600 rad) irradiated mice, and analyzed approximately 2.5 weeks later. Thymocytes were transduced with TCR vector containing no reporter, an IRES-Thy1.1 or an IRES-huCD2 prior to injection.
Naive T cell transfer studies Foxp3 -CD44 lo CD62L hi G25 TCR transgenic Rag1 -/-cells were sorted and retro-orbital injected into indicated mice. In some experiments, cells were first labeled with Cell Trace Violet (Thermo Fisher). For histological studies, 6-8-week-old littermate male TCRbd -/-mice were used. In peripheral activation studies, 6-8-week-old littermate Batf3 +/-and Batf3 -/-mice were used. 10 5 naive T cells were injected per mouse. For peripheral activation studies, pooled lymph nodes and spleens were harvested 4 days after transfer.
Allogeneic bone marrow chimeras, mixed lymphocyte reaction, and acute GVHD Initial BM chimeras were performed as described above. Eight weeks post-transplant, thymic CD62L hi CD24 lo CD4SP Tconv cells were sorted. For in vitro experiments, sorted cells were CTV labeled and co-cultured with irradiated (2000 rad) splenocytes from BALB/c mice. Samples were analyzed for CD25 expression and CTV dilution 5 days post co-culture. Donor Tconv cells were distinguished from BALB/c splenocytes by H-2K b (AF6-88.5) and H-2K d (SF1-1.1) expression. For in vivo experiments, 10 6 sorted Tconv cells were injected into lethally-irradiated BALB/c mice concurrently receiving allogenic 5x10 6 T cell-depleted C57BL/6 BM. In some experiments, Tconv cells came from adult mice instead of from BM chimeras. Mice were assessed for weight loss beginning 4 days post injection. Mice were sacrificed after R 20% loss of initial body weight. Additionally, mice were scored for disease severity using a standard 10 point scale that assesses weight loss, posture, mobility, fur texture, and skin integrity (Cooke et al., 1996) .
QUANTIFICATION AND STATISTICAL ANALYSIS
For TCR analysis, only TRAVs with summed reads greater than 1% in the WT multiplex TCR data were analyzed. This accounted for more than 95% of the total TRAV repertoire. TRAV_CDR3 species frequencies were then multiplied by a correction factor determined by the ratio of template switch TRAV frequency (Mamedov et al., 2013) to multiplex TRAV frequency using data obtained from 2 biological replicates each with 2 technical replicates sequenced both ways. These frequencies were used to determine the number of a particular TRAV_CDR3 clonotype (clonotypes determined via IMGT, (Giudicelli et al., 2006) ). All data were rarefied to the smallest sample size. Rarefaction was performed 10 times. Student's t tests, one-way ANOVAs, or two-way repeated-measures ANOVAs with Tukey's post hoc test was used for between-subjects analyses unless otherwise noted.
DATA AND SOFTWARE AVAILABILITY
Graphpad Prism v6, IBM SPSS v21, and R v3.2.3 were used for used for graphical and statistical analysis and are available commercially or via open source sharing (R v3.2.3). The R package DESeq2 (v1.10.3) was used for differential TCR expression analysis; and vegan (v2.3-5) for dimensional analysis, rarefaction, and visualization. TCR data is availability via the European Nucleotide Archive (ENA) under the accession #PRJEB25804. All code is available upon request.
